medigraphic.com

2015, Number S1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (S1)

Prevalence and implicated risk factors associated with the exteriorization of cardiac pacemakers: 5 year follow-up

Argüello-Hurtado M, Guevara-Valdivia ME, Aranda- Ayala ZL, Hernández-Lara J

Language: Spanish
References: 17
Page: 104-108
PDF size: 279.45 Kb.


ABSTRACT

Background: Infection is the most common complication related to permanent pacemaker implantation. The objetive of this study is to establish the prevalence and determine the frequency of risk factors associated with exteriorization of cardiac pacemakers at the Department of Cardiac Electrophysiology at the UMAE Hospital de Especialidades “Dr. Antonio Fraga Mouret” Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social.
Methods: A descriptive cross-sectional study from September 2005 to September 2010, where, for the analysis of the risk factors we selected cases and controls by age, sex and the diagnosis of Diabetes, or not. Was calculated measures of central tendency (mean, median and mode) and chi-squared, Fisher exact test and exact odds ratio.
Results: 3192 cardiac pacemakers were implanted, identifying 83 exteriorization cases, where 46 of them were selected for cases and controls, and the mean age was 71 years.
Conclusions: Our prevalence of exteriorization of cardiac pacemakers is 2.6 %, these results are similar to previously published studies. None of the risk factors described are present as a cause in our population. The surgical technique used may be an important risk factor, so further studies analysing all techniques are needed.


REFERENCES

  1. Harris AM. Endocardial pacing. Am Heart J. 1966; 72:135-7.

  2. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15:1070-118.

  3. Coma Samartín R, Ruiz Mateas F, Fidalgo Andrés ML, Leal del Ojo González J, Pérez Álvarez L. Registro Español de Marcapasos. X Informe Ofi cial de la Sección de Estimulación Cardiaca de la Sociedad Española de Cardiología (2012). Rev Esp Cardiol 2013;66:959-72.

  4. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on Cardiovascular Implantable Electronic Device Infections and Their Management. Circulation. 2010;121: 458-77.

  5. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006; 48:590-1.

  6. Bloom H1, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, et al Renal Insuffi ciency and the Risk of Infection from Pacemaker or Defi brillator Surgery. Pacing Clin Electrophysiol. 2006; 29:142-5.

  7. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR. Et al Risk Factor Analysis of Permanent Pacemaker Infection. Clin Infect Dis. 2007;45:166-73

  8. Klug D1, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N.et al Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter- Defi brillators. Results of a Large Prospective Study. Circulation 2007;116:1349-55.

  9. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A. et al Antibiotic Prophylaxis for Permanent Pacemaker Implantation: A Meta- Analysis. Circulation 1998; 97: 1796-1801.

  10. Izquierdo M, Bonanad C, Madrazo I, Ferrero A, Martínez A, Morell S, et al Evolución de los pacientes con complicaciones locales en la bolsa del generador de un dispositivo implantable Arch Cardiol Mex. 2014;84:4-9.

  11. Lekkerkerker JC, van Nieuwkoop C, Trines SA, van der Bom JG, Bernards A, van de Velde ET. Et al Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009;95:715-20.

  12. Mounsey JP, Griffi th MJ, Tynan M, Gould FK, Mac- Dermott AF, Gold RG. et al Antibiotic prophylaxis reduces reoperation rate for infective complications following permanent cardiac pacemaker implantation: a prospective randomized trial. Circulation.1993; 88(suppl I):I19.

  13. Koutentakis M, Siminelakis S, Korantzopoulos P, Petrou A, Priavali H, Mpakas A, et al. Surgical management of cardiac implantable electronic device infections. J Thorac Dis. 2014 Suppl 1:S173-9.

  14. Marine JE ,. Brinker JA. Techniques of pacemaker implantation and removal en Ellenbogen KA. Kaszala K . Cardiac Pacing and ICDs. NJ, USA, 6th Edition John Wiley & Sons, Ltd. 2014,p.150-210.

  15. Shimada H1, Hoshino K, Yuki M, Sakurai S, Owa M. Percutaneous cephalic vein approach for permanent pacemaker implantation. Pacing Clin Electrophysiol. 1999;22:1499-501.

  16. Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Menon SM. et al Device-Related Infection Among Patients With Pacemakers And Implantable Defi brillators: Incidence, Risk Factors, and Consequences. J Cardiovasc Electrophysiol, 2010;21: 786-90.

  17. Rajappan K. Permanent pacemaker implantation technique: Part I. Heart 2009;95:259-64.




2020     |     www.medigraphic.com